-
1 Comment
PolarityTE, Inc is currently in a long term downtrend where the price is trading 18.0% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.1.
PolarityTE, Inc's total revenue rose by 144.9% to $4M since the same quarter in the previous year.
Its net income has increased by 100.0% to $-10K since the same quarter in the previous year.
Finally, its free cash flow grew by 65.2% to $-6M since the same quarter in the previous year.
Based on the above factors, PolarityTE, Inc gets an overall score of 4/5.
Exchange | NASDAQ |
---|---|
CurrencyCode | USD |
ISIN | US7310941080 |
Sector | Healthcare |
Industry | Biotechnology & Medical Research |
Market Cap | 2M |
---|---|
PE Ratio | None |
Target Price | 0.8 |
Dividend Yield | 0.0% |
Beta | 1.15 |
PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PTE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025